Centrum Onkologii-Instytut im. M. Sklodowskiej Curie

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)	Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 2	2026-07-14		NCT02864992
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, gastrointestinal stromal tumor, neoplasm	Active, not recruiting	Phase 3	2026-02-05		NCT03673501

Clinical trials